News from
Science, Economy
and the BIO.NRW network
News
GEC Call for Solutions
The Global Entrepreneurship Centre (GEC) supports transformative companies that focus on sustainable technologies (sustech) for achieving circularity, the global climate targets of the Paris Accord and the Sustainable Development Goals of the ...
Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides
based on a German press release dated 06 July 2023 Numaferm, a Germany-based biotech company, specialized in the production of pepteins, and Zoetis, the global leading animal health company, have signed a ...
MUT – DER GRÜNDUNGSPREIS NRW 2023 Now Accepting Applications
based on a German press release dated 19 June 2023 Prize money totalling € 60,000 for founders from North Rhine-Westphalia Düsseldorf. Founders from North Rhine-Westphalia can now apply for the prize recognizing the best ...
BIO.NRW goes USA
From 5 to 8 June 2023, the Boston Convention and Exhibition Center once again opened its doors for the BIO International Convention, which is probably the largest and most important event in ...
10th BioRiver Boost! 2023
All young start-ups and founding projects in the life sciences and biotechnology sectors, including agritech, are invited to apply for BioRiver Boost! 2023. By participating in the competition you apply for: 1 ...
DNTOX receives €1.4 million seed funding for non-animal testing of chemicals
Press release June, 14 2023 The life science startup enables non-animal testing of chemicals for neurotoxicity. DNTOX receives €1.4 million from High-Tech Gründerfonds (HTGF), private investors Barbara Korte-Sturm and Nikolaus Sturm, Bool ...
News archive
No posts found.
Biotech Beats with David Spencer
We are looking forward to our keynote speaker, molecular biologist and science communicator David Spencer. He holds a PhD in ...
The upcyclers from Münster – a visit
They are well known in the cities: the old clothes containers. Rarely beautiful, often overcrowded. And it is not only ...
European Biotech Week: Showcasing the Transformative Power of Biotechnology
Press release Brussels, 31 July 2023 EuropaBio and Members are proud to launch the 11th edition of European Biotech Week ...
11. BIO.NRW Business Angel Congress – Follow up
The 11. International BIO.NRW Business Angel Congress was held on 8th of March at the place to be forty four ...
Pioneers from NRW – Dr. Henke explains why the reddest salmon comes from Bielefeld
The first pioneer to feature in BIO.NRW’s interview series “Pioneers from NRW” is molecular biologist Dr. Nadja Henke from Bielefeld ...
Announcement: Start of new Interview Series “Pioneers from NRW” to Start on April 26th 2022
On April 26th, we will present the first pioneer in our new interview series “Pioneers from NRW”. About once every ...
Bio NRW
The Innovation Centre-3Rs (IC-3Rs) at the Vrije Universiteit Brussel (VUB) organizes a video contest that is open to all interested ...
Neonatal Diagnostics Company InfanDx AG Completes Series A Funding
Company raises EUR 4 million to reach key value-creating milestones over the next 12-18 months Klaus Albrecht, Alluti GmbH, appointed ...
Evonik acquires German biotech company JeNaCell to expand biomaterials portfolio for new medical device markets
Nanostructured biomaterial for wound dressings and dermatology to be integrated into Health Care business Evonik Venture Capital’s early investment in ...
BIO.NRW and ZENIT GmbH in cooperation – The new brochure of selected funding tools for the life sciences is now available
At the end of April this year, the European Parliament finally approved the legislative texts for the EU's new research ...
Publication of the Work Program 2021-2022 of the Horizon Europe Cluster Health
The EU Commission has published the Horizon Europe work program in cluster 1. Among other things, this contains the calls ...
Phase II Clinical Trial of the COVID-19 Vaccine of Janssen Authorised in Germany
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has approved the Phase II clinical trial of the SARS-CoV-2 vaccine candidate ...
Corona platform of the EU with information on funding opportunities related with Covid-19
The platform is a one-stop-shop providing comprehensive information about funding opportunities in relation to Coronavirus at European Union and national ...
Overview of COVID-19 associated (and general) funding, financing, information
BIO.NRW offers you here a selection and overview of funding and support programs in connection with the COVID-19 pandemic. Please ...
QIAGEN supports the location of Hilden with the biggest investment of the company’s history; the state government supports with 18 M €
Qiagen invests more than 110 M € in Hilden, Maryland, and Barcelona to expand its production capacity of Corona tests ...
No posts found.
No posts found.
No posts found.